# APH1A

## Overview
APH1A is a gene that encodes the protein aph-1 homolog A, a critical subunit of the γ-secretase complex, which is a multi-protein transmembrane complex involved in the intramembrane proteolysis of several type I transmembrane proteins, including the amyloid precursor protein (APP) and Notch receptors. The APH1A protein is characterized by its seven transmembrane domains, which are essential for its role in the assembly and function of the γ-secretase complex (Li2014Structural; Chiang2012Specific). This protein is crucial for the stability and maturation of the complex, influencing processes such as cellular signaling and development (Ma2005APH1a; Lee2002Mammalian). Variants of APH1A, resulting from alternative splicing, contribute to the formation of distinct γ-secretase complexes, which have implications in neurological conditions such as Alzheimer's disease due to their role in amyloid-β peptide production (Shirotani2004Identification; Watanabe2022Specific).

## Structure
The APH1A protein is a component of the γ-secretase complex, characterized by seven transmembrane domains (TMDs) with its N-terminus located in the endoplasmic reticulum/extracellular space and its C-terminus in the cytosol (Li2014Structural; Chiang2012Specific). These TMDs are crucial for the protein's function, with specific domains such as TMD4 and TMD5 being essential for forming the initial subcomplex with nicastrin (Nct), while TMD3 and TMD6 are important for the association and endoproteolysis of presenilin (PS) (Chiang2012Specific). The protein includes a conserved GXXXG motif in TMD4, which is vital for the assembly and maturation of the γ-secretase complex (Li2014Structural; Chiang2012Specific).

APH1A exists in two C-terminal splicing variants: APH-1aL (long variant) and APH-1aS (short variant), which form distinct γ-secretase complexes (Shirotani2004Identification; Chiang2012Specific). These variants are expressed in both peripheral and neuronal cells, with APH-1aS being the predominant form in certain cell types (Shirotani2004Identification). The protein's structure and specific mutations can influence γ-secretase activity, impacting amyloid precursor protein processing, which is relevant to Alzheimer's disease research (Watanabe2022Specific).

## Function
APH1A encodes a protein that is a critical component of the γ-secretase complex, which is essential for the intramembrane proteolysis of several type I transmembrane proteins, including the amyloid precursor protein (APP) and the Notch receptor. This proteolytic activity is crucial for cellular signaling and development (Ma2005APH1a; Lee2002Mammalian). APH1A is predominantly active in intracellular membrane compartments such as the endoplasmic reticulum and the cis-Golgi, where it contributes to the assembly and stability of the γ-secretase complex (Gu2003APH1).

The protein interacts with other components of the γ-secretase complex, including presenilin and nicastrin, facilitating the maturation and trafficking of these complexes (Gu2003APH1). APH1A is involved in maintaining the stability of presenilin NTF:CTF heterodimers, which are crucial for the function of the γ-secretase complex (Lee2002Mammalian). The absence of APH1A leads to reduced levels of mature nicastrin and other γ-secretase components, impairing APP processing and decreasing the secretion of amyloid-β peptides (Ma2005APH1a). This highlights its essential role in the formation and function of the γ-secretase complex, which is vital for normal cellular processes.

## Clinical Significance
The APH1A gene is implicated in Alzheimer's disease (AD) through its role in the gamma-secretase complex, which is involved in the production of amyloid-beta (Aβ) peptides, a key factor in AD pathogenesis. A specific single-nucleotide polymorphism (SNP), -980C/G, in the promoter region of the APH1A gene has been associated with an increased risk of AD. This polymorphism enhances the binding affinity of the transcription factor Yin Yang 1 (YY1), leading to elevated APH1A mRNA and protein levels, which in turn increase gamma-secretase activity and Aβ production (Qin2011The). Studies have shown that individuals carrying the G allele of this polymorphism have a higher risk of developing AD, with the GG genotype being particularly associated with an increased risk (Wang2009Association).

The interaction of the G allele with the APOE ε4 allele further elevates the risk of sporadic AD, suggesting a gene-gene interaction that exacerbates disease susceptibility (Wang2009Association). These findings highlight the clinical significance of APH1A in AD, suggesting that targeting the regulatory mechanisms of APH1A expression could be a potential therapeutic strategy (Qin2011The).

## Interactions
APH1A is a component of the γ-secretase complex, which is involved in the intramembrane proteolysis of type I membrane proteins, including the amyloid precursor protein (APP) and Notch receptors. APH1A interacts with other subunits of the γ-secretase complex, specifically nicastrin (NCT) and presenilin (PS). The interaction between APH1A and NCT is crucial for the formation of an intermediate subcomplex, which is an early step in the assembly of the γ-secretase complex. This subcomplex consists of APH1A and immature NCT (iNCT) and is distinct from the mature γ-secretase complex that includes PS and PEN-2 (LaVoie2003Assembly).

Mutations in specific transmembrane domains (TMDs) of APH1A, such as TMD4 (G126) and TMD5 (H171), can prevent the formation of the NCT/APH1A subcomplex, highlighting the importance of these domains for protein interactions within the complex (Chiang2012Specific). APH1A also shows a specific binding preference for iNCT over mature NCT (mNCT), indicating its role in stabilizing nascent NCT during the early stages of complex assembly (LaVoie2003Assembly). These interactions are essential for the formation of a mature, active γ-secretase enzyme.


## References


[1. (Gu2003APH1) Yongjun Gu, Fusheng Chen, Nobuo Sanjo, Toshitaka Kawarai, Hiroshi Hasegawa, Monica Duthie, Wenping Li, Xueying Ruan, Anchla Luthra, Howard T.J. Mount, Anurag Tandon, Paul E. Fraser, and Peter St George-Hyslop. Aph-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin·nicastrin complexes. Journal of Biological Chemistry, 278(9):7374–7380, February 2003. URL: http://dx.doi.org/10.1074/jbc.m209499200, doi:10.1074/jbc.m209499200. This article has 123 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m209499200)

[2. (Lee2002Mammalian) Sheu-Fen Lee, Sanjiv Shah, Hongqiao Li, Cong Yu, Weiping Han, and Gang Yu. Mammalian aph-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-β precursor protein and notch. Journal of Biological Chemistry, 277(47):45013–45019, November 2002. URL: http://dx.doi.org/10.1074/jbc.m208164200, doi:10.1074/jbc.m208164200. This article has 170 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m208164200)

[3. (Li2014Structural) Yi Li, Christopher Bohm, Roger Dodd, Fusheng Chen, Seema Qamar, Gerold Schmitt-Ulms, Paul E Fraser, and Peter H St George-Hyslop. Structural biology of presenilin 1 complexes. Molecular Neurodegeneration, December 2014. URL: http://dx.doi.org/10.1186/1750-1326-9-59, doi:10.1186/1750-1326-9-59. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1750-1326-9-59)

[4. (Wang2009Association) Yan Wang and Jianping Jia. Association between promoter polymorphisms in anterior pharynx-defective-1a and sporadic alzheimer’s disease in the north chinese han population. Neuroscience Letters, 455(2):101–104, May 2009. URL: http://dx.doi.org/10.1016/j.neulet.2009.02.015, doi:10.1016/j.neulet.2009.02.015. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neulet.2009.02.015)

[5. (Qin2011The) Wei Qin, Longfei Jia, Aihong Zhou, Xiumei Zuo, Zhe Cheng, Fen Wang, Fudong Shi, and Jianping Jia. The −980c /g polymorphism in aph‐1a promoter confers risk of alzheimer’s disease. Aging Cell, 10(4):711–719, May 2011. URL: http://dx.doi.org/10.1111/j.1474-9726.2011.00708.x, doi:10.1111/j.1474-9726.2011.00708.x. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1474-9726.2011.00708.x)

[6. (LaVoie2003Assembly) Matthew J. LaVoie, Patrick C. Fraering, Beth L. Ostaszewski, Wenjuan Ye, W.Taylor Kimberly, Michael S. Wolfe, and Dennis J. Selkoe. Assembly of the γ-secretase complex involves early formation of an intermediate subcomplex of aph-1 and nicastrin. Journal of Biological Chemistry, 278(39):37213–37222, September 2003. URL: http://dx.doi.org/10.1074/jbc.m303941200, doi:10.1074/jbc.m303941200. This article has 160 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m303941200)

[7. (Ma2005APH1a) Guojun Ma, Tong Li, Donald L. Price, and Philip C. Wong. Aph-1a is the principal mammalian aph-1 isoform present in γ-secretase complexes during embryonic development. The Journal of Neuroscience, 25(1):192–198, January 2005. URL: http://dx.doi.org/10.1523/jneurosci.3814-04.2005, doi:10.1523/jneurosci.3814-04.2005. This article has 79 citations.](https://doi.org/10.1523/jneurosci.3814-04.2005)

[8. (Shirotani2004Identification) Keiro Shirotani, Dieter Edbauer, Stefan Prokop, Christian Haass, and Harald Steiner. Identification of distinct γ-secretase complexes with different aph-1 variants. Journal of Biological Chemistry, 279(40):41340–41345, October 2004. URL: http://dx.doi.org/10.1074/jbc.m405768200, doi:10.1074/jbc.m405768200. This article has 129 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m405768200)

[9. (Watanabe2022Specific) Hikari Watanabe, Chika Yoshida, Masafumi Hidaka, Tomohisa Ogawa, Taisuke Tomita, and Eugene Futai. Specific mutations in aph1 cause γ-secretase activation. International Journal of Molecular Sciences, 23(1):507, January 2022. URL: http://dx.doi.org/10.3390/ijms23010507, doi:10.3390/ijms23010507. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23010507)

[10. (Chiang2012Specific) Po-Min Chiang, Ryan R. Fortna, Donald L. Price, Tong Li, and Philip C. Wong. Specific domains in anterior pharynx-defective 1 determine its intramembrane interactions with nicastrin and presenilin. Neurobiology of Aging, 33(2):277–285, February 2012. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2009.12.028, doi:10.1016/j.neurobiolaging.2009.12.028. This article has 6 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2009.12.028)